Servicios Personalizados
Revista
Articulo
Español (pdf)
Artículo en XML
Referencias del artículo
Traducción automática
Enviar artículo por emailIndicadores
Citado por SciELO 
Accesos
Links relacionados
Similares en
SciELO
Compartir
Permalink
Gaceta mexicana de oncología
versión On-line ISSN 2565-005Xversión impresa ISSN 1665-9201
Resumen
CHACON-ANAYA, Silvia C.; DURAN-CRUZ, Mauricio; REDING-BERNAL, Arturo y BARRAGAN-PEREZ, José A.. Dosimetric analysis between Mánchester points A and high-risk clinical target volume in the three-dimensional image-guided branchytherapy for uterine cervical cancer. Gac. mex. oncol. [online]. 2021, vol.20, n.1, pp.4-11. Epub 16-Abr-2021. ISSN 2565-005X. https://doi.org/10.24875/j.gamo.200000311.
Background:
Gynecological brachytherapy has evolved from the concept of punctual prescription (Manchester) to treatment volumes.
Objective:
To analyze the dosimetric result between the prescription at point A and high-risk clinical target volume (HR-CTV).
Methods:
Both plans were performed in 28 patients with stage IB2-IVA cervical cancer (112 applications), the dose used was 4 fractions of 5.62 Gy.
Results:
The mean D90 (dose to 90% volume) and its standard deviation for HR-CTV: 92.1 ± 2.7 Gy, was lower (p < 0.008) than at points A (103.4 ± 21.6 Gy). HR-CTV coverage: 97.8 ± 7.3% was higher (p < 0.000000000043) than with points A (86.6 ± 14.7%). The bladder D2 cc was: 83.8 ± 22.4 Gy vs. ICRU 38 bladder point (66.1 ± 7.6 Gy) (p < 0.0057), demonstrating the underestimation of the dose in the punctual planning. The D2 cc of the rectum was: 73.6 ± 12.7 Gy vs. ICRU 38 straight point (75.1 ± 11.9 Gy) (p < 0.4857), not differing significantly.
Conclusions:
3D brachytherapy provides greater dose coverage for HR-CTV compared to the traditional system, with an underestimation of the dose received in the bladder in the punctual system.
Palabras llave : Cervical cancer; Brachytherapy; Intracavitary; Manchester; Volumetric.
